Longitudinal patient-reported outcomes correlated with biomarkers and treatment response. The data HEOR teams need, generated by patients who want to advance research.
Different teams need different insights from patient data. Here's what PathwayBio enables for each.
Build payer dossiers with patient-reported outcomes that demonstrate real-world value. Show treatment effectiveness beyond clinical trial endpoints.
Accelerate trial recruitment with pre-qualified patients who match your eligibility criteria and have opted in to research opportunities.
Understand why patients discontinue therapy before they do. Sentiment signals and adherence patterns reveal intervention opportunities.
Generate publication-ready evidence from real patient populations. Support KOL discussions with authentic outcome data.
A complete pipeline from ethically-sourced patient data to team-specific deliverables.
How patient-generated data becomes research-ready evidence
CRP, ESR, ANA, metabolic panels
Symptoms, QoL, daily check-ins
Treatments, dosing, switches
AI-analyzed patient narratives
Research-ready data formats covering the full patient experience over time.
Inflammatory markers, autoimmune antibodies, metabolic panels
Daily severity scores, quality of life, flare patterns
Treatment history, biologics, switching patterns
AI-analyzed narratives, concerns, treatment perceptions
Traditional RWE extracts value from patients without their knowledge. PathwayBio inverts this model: patients actively choose to share data, understand how it's used, and receive direct compensation.
This isn't just ethics—it's better data. Engaged patients provide richer, more complete records than passive EHR extraction.
RESTful API with comprehensive documentation. Query cohorts, access longitudinal data, and integrate directly into your research workflows.
From pilot evaluations to enterprise partnerships. All tiers include HIPAA compliance and BAA.
3-month pilot to validate data fit for your research needs
Full platform access for ongoing research programs
Custom integrations and co-development opportunities
We're selectively onboarding research partners who can help shape the platform while gaining early access to patient-generated RWE.